These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32141682)

  • 21. Brain abnormalities detected on magnetic resonance imaging of amphetamine users presenting to an emergency department: a pilot study.
    Fatovich DM; McCoubrie DL; Song SJ; Rosen DM; Lawn ND; Daly FF
    Med J Aust; 2010 Sep; 193(5):266-8. PubMed ID: 20819043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.
    Kaland ME; Klein-Schwartz W
    Clin Toxicol (Phila); 2015 Jun; 53(5):477-85. PubMed ID: 25832473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study.
    Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J
    Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key differences in treatment-seeking stimulant users attending a specialised treatment service: a means of early intervention?
    Arunogiri S; Petrie M; Sharkey M; Lubman DI
    Australas Psychiatry; 2017 Jun; 25(3):246-249. PubMed ID: 28068828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compliance with telephone triage advice among adults aged 45 years and older: an Australian data linkage study.
    Tran DT; Gibson A; Randall D; Havard A; Byrne M; Robinson M; Lawler A; Jorm LR
    BMC Health Serv Res; 2017 Aug; 17(1):512. PubMed ID: 28764695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood.
    Jones AW; Holmgren A; Kugelberg FC
    J Stud Alcohol Drugs; 2008 Mar; 69(2):202-8. PubMed ID: 18299760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada.
    Morin KA; Vojtesek F; Acharya S; Marsh DC
    Front Psychiatry; 2021; 12():782066. PubMed ID: 34987430
    [No Abstract]   [Full Text] [Related]  

  • 28. Escalating patterns of emergency health care prior to first admission with amphetamine psychosis: A window of opportunity?
    Sara G; Lappin J; Dobbins T; Dunlop AJ; Degenhardt L
    Drug Alcohol Depend; 2017 Nov; 180():171-177. PubMed ID: 28903079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulant expectancy questionnaire for men who have sex with men: A measure of substance-related beliefs.
    Mullens AB; Fein EC; Young RM; Dunne MP; Norton G; Daken K
    Health Promot J Austr; 2020 Apr; 31(2):309-319. PubMed ID: 31225931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining factors for the increase in self-referrals to the Emergency Department of a rural hospital in Huelva (Spain).
    Pino-Moya E; Ortega-Moreno M; Gómez-Salgado J; Ruiz-Frutos C
    PLoS One; 2018; 13(11):e0207199. PubMed ID: 30485300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methamphetamine use in patients presenting to emergency departments and psychiatric inpatient facilities: what are the service implications?
    Unadkat A; Subasinghe S; Harvey RJ; Castle DJ
    Australas Psychiatry; 2019 Feb; 27(1):14-17. PubMed ID: 30382752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.
    Wu LT; Pilowsky DJ; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):195-205. PubMed ID: 17257780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of amphetamine-type stimulant abuse through hair analysis: Results from 12 years of work.
    Brčić Karačonji I; Brajenović N
    Arh Hig Rada Toksikol; 2014 Jun; 65(2):225-30. PubMed ID: 24945418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy.
    Carrico AW; Hunt PW; Neilands TB; Dilworth SE; Martin JN; Deeks SG; Riley ED
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):89-93. PubMed ID: 30272634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and correlates of amphetamine-type stimulant use among transgender women in Cambodia.
    Mburu G; Tuot S; Mun P; Chhoun P; Chann N; Yi S
    Int J Drug Policy; 2019 Dec; 74():136-143. PubMed ID: 31590089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriateness of cases presenting in the emergency department following ambulance service secondary telephone triage: a retrospective cohort study.
    Eastwood K; Smith K; Morgans A; Stoelwinder J
    BMJ Open; 2017 Oct; 7(10):e016845. PubMed ID: 29038180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency department referral patterns of Australian general practitioner registrars: a cross-sectional analysis of prevalence, nature and associations.
    Catzikiris N; Tapley A; Morgan S; van Driel M; Spike N; Holliday EG; Ball J; Henderson K; McArthur L; Magin P
    Aust Health Rev; 2019 Feb; 43(1):21-28. PubMed ID: 29117892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using population screening for recruitment of young adults engaged in illicit drug use: methodological issues and sampling outcomes.
    Smirnov A; Kemp R; Wells H; Legosz M; Najman JM
    Soc Sci Res; 2014 May; 45():89-97. PubMed ID: 24576629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia.
    Chalmers J; Lancaster K; Hughes C
    Int J Drug Policy; 2016 Oct; 36():15-24. PubMed ID: 27450550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.